1ISIS - 2 (Second international study of infarct survival)collaborative group. Randomized trial of intravenous thrombolytic in acute myocardial infarction. Lancet, 1988,2:349～360
2GLSSI - 2. A factorial randomized trial of alteplase versus strepokinase and heparin versus no heparin among12 490patients with AMI. Lancet, 1990,336: 65 ～ 71
3The ISIS - 3(Third international study of infarct survival)collaborative group. ISIS - 3: a randomized comparison of streptokinase vs tissue plasminogen activator vs antistreptokinase and of aspirin plus heparin vs aspirin alone among 4 1299 cases of suspected acute myocardial infarction. Lancet, 1992,339 : 753～ 770
